GeneDx growth playbook

Add a coverage lookup to the General Pediatrics page: pick a state and plan type and see whether first-line exome for GDD/ID is covered, whether prior authorization is typical, what documentation helps, and the financial assistance fallback. Use one current count of Medicaid states everywhere, dated, and link the lookup from the homepage, the RAE email signature and the SAVES-Kids post.

Coverage uncertainty is the main reason a generalist does not order a test they believe in. Answering it on the page turns the AAP recommendation into orders without a rep visit for every question, and gives the reps a link to leave behind.

[ ] One Medicaid state count, dated, on homepage and General Pediatrics
[ ] Table: state, plan type, first-line ES policy, prior auth, date checked
[ ] Compliance-approved caveat wording
[ ] Documentation checklist for GDD/ID orders
[ ] Financial assistance fallback
[ ] Link from SAVES-Kids post and RAE leave-behinds
[ ] Monthly review owner

• Coverage changes faster than the page

  Show the date checked and link each plan policy.

• Read as a guarantee

  State clearly that coverage is confirmed per patient.

• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source
• Your websiteHomepage: "Preferred by more than 75,000 clinicians"; "Covered by most major insurers, with Medicaid coverage in 38 states"; "1M+ Exomes and genomes sequenced" in one block and "nearly 1 million exomes and genomes, and 7 million phenotypic data points" in the Infinity block; the carousel still promotes "Prenatal Webinar | July 8 at 3 pm ET"; visible typos such as "genoome sequencing" and "inheritedconditions".Source
• Your websiteCommercial insurance contracts page: "Click on your state below to see a list of health plans contracted with GeneDx", with the caveat "Contract status does not equal coverage. Please refer to each health plan medical policy for coverage information."Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source
• HiringProduct Lead, Revenue Cycle Management (posted October 20, 2026): first focus on "improving prior authorization, automating document intake, identifying coverage earlier, increasing clinical completeness"; KPIs include "coverage found rate, self-pay-to-billable conversion", "packets complete at first submission" and "patient financial experience and self-pay".Source
• Your blogSAVES-Kids (published October 2, 2026): in 5,821 Medicaid-covered children, stepwise testing "added an average of 19 months and $2,039 in genetic testing costs before" exome or genome sequencing; first-tier sequencing was associated with "$294 in savings per patient per year"; "some plans continue to require prior genetic testing before authorizing ES/GS".Source

Offer a guided first order: register and start the order in one flow, verify the NPI automatically, and hold the order for review instead of blocking it. Add a printable requisition path for the first order and a "start an order" link reps can text to a practice.

Removing the wait at the first order is the cheapest way to turn a convinced generalist into an ordering account.

• Unverified orders

  Hold processing until verification completes.

• Your websiteHow to order: a new clinician registers in the provider portal and "Our team will verify your new account"; anyone needing to order immediately is pointed to their assigned Regional Account Executive or Client Success Manager; Epic Aura users can order in the EHR; "Providing detailed and complete information upfront" can "Increase the likelihood that testing will be approved by insurance."Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source
• HiringRegional Account Executive - Specialty (DC/Alexandria, posted October 15, 2026): focused "within genetics & pediatric segments", "Accountable for lead generation in an assigned territory" and for "physician and staff satisfaction"; "Implements agreed upon sales and marketing plans".Source

Create one dated fact sheet of headline numbers (tests, exomes and genomes, phenotypic data points, contactable patients, clinicians, Medicaid states, turnaround) owned by one person, and pull every page's figures from it in Webflow.

Consistent, dated numbers read as rigor; inconsistent ones invite questions about the data itself.

• Numbers grow weekly

  Use rounded, dated values.

• Your websiteHomepage: "Preferred by more than 75,000 clinicians"; "Covered by most major insurers, with Medicaid coverage in 38 states"; "1M+ Exomes and genomes sequenced" in one block and "nearly 1 million exomes and genomes, and 7 million phenotypic data points" in the Infinity block; the carousel still promotes "Prenatal Webinar | July 8 at 3 pm ET"; visible typos such as "genoome sequencing" and "inheritedconditions".Source
• Your websiteBiopharma page: Infinity with "9M+ structured phenotypic data points" in one section and "7 million+ Phenotypic datapoints" further down; "400K contactable patients and providers"; "92% overlapping patient tokens with Komodo's Research Dataset"; "More than 50% of data is from non-European ancestry"; teams served are Clinical Development, Medical Affairs, RWE and HEOR; the call to action is "Contact our team" and there are no partner case studies.Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source
• HiringDirector of Business Development, Biopharma Partnerships (posted October 13, 2026): grows "real-world data (RWD) and real-world evidence (RWE) partnerships" with pharma, biotech, digital health and medtech, owning "$2M-$10M+ MSAs", and will "Represent GeneDx at major industry conferences ... to elevate brand visibility and generate inbound opportunities".Source

Replace the July slide with the recording or the next webinar, correct the typos, and find the shifting elements (usually carousels, late fonts and images without set dimensions) in Webflow; reserve their space and retest.

Clinicians judge a lab's precision by small things, and layout stability is part of how Google ranks pages.

• Design changes

  Keep layout, set dimensions only.

• Your websiteHomepage: "Preferred by more than 75,000 clinicians"; "Covered by most major insurers, with Medicaid coverage in 38 states"; "1M+ Exomes and genomes sequenced" in one block and "nearly 1 million exomes and genomes, and 7 million phenotypic data points" in the Infinity block; the carousel still promotes "Prenatal Webinar | July 8 at 3 pm ET"; visible typos such as "genoome sequencing" and "inheritedconditions".Source
• Google PageSpeedReal Chrome visitors (Chrome UX Report, 75th percentile): LCP 1.9 s and INP 128 ms pass, but Cumulative Layout Shift is 0.17, above the 0.1 threshold, so the origin fails Core Web Vitals on layout stability. The site runs on Webflow.Source

Label each event by audience (developmental pediatrics, health system leaders, genetic counselors, epilepsy), add a meeting booking link to every card routed to the right team, and publish a follow-up page per event with the session materials.

Booked meetings before the event are worth more than booth traffic, and correct labels help the right audience find the right event.

• Too few staff to meet

  Limit slots and add virtual options.

• Your websiteConferences & Events page: Society for Developmental and Behavioral Pediatrics (October 23-27), Becker's Healthcare CEO + CFO (November 2-5), NSGC (November 10-14) and American Epilepsy Society (December 4-8, booth #1805). Every event card carries the same "Journal of Genetic Counseling" label.Source
• HiringDirector of Business Development, Biopharma Partnerships (posted October 13, 2026): grows "real-world data (RWD) and real-world evidence (RWE) partnerships" with pharma, biotech, digital health and medtech, owning "$2M-$10M+ MSAs", and will "Represent GeneDx at major industry conferences ... to elevate brand visibility and generate inbound opportunities".Source
• HiringEHR hiring: an Epic Analyst (posted October 12, 2026) whose objective is to "Enable smooth and swift Epic Aura integration projects with new customers quarterly", and an EHR Implementation Manager familiar with "Epic, Aura, Cerner, eClinicalWorks, and other Electronic Health Record platforms".Source

Publish a downloadable kit: a one-page eligibility guide for GDD/ID, a documentation checklist and template letter of medical necessity, common ICD-10 codes, and a parent handout linked to the families quiz. Reps leave it at every visit; the site offers it on the General Pediatrics page.

A practical kit moves a pediatrician from agreeing with the guideline to ordering, and complete documentation improves approval rates.

• Templates misused

  Keep them guidance, reviewed by medical affairs.

• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source
• Your websiteHow to order: a new clinician registers in the provider portal and "Our team will verify your new account"; anyone needing to order immediately is pointed to their assigned Regional Account Executive or Client Success Manager; Epic Aura users can order in the EHR; "Providing detailed and complete information upfront" can "Increase the likelihood that testing will be approved by insurance."Source
• HiringProduct Lead, Revenue Cycle Management (posted October 20, 2026): first focus on "improving prior authorization, automating document intake, identifying coverage earlier, increasing clinical completeness"; KPIs include "coverage found rate, self-pay-to-billable conversion", "packets complete at first submission" and "patient financial experience and self-pay".Source
• Your websiteFamilies: an "Is genetic testing right for you?" quiz, a "Talk to your doctor" page, and a billing page saying GeneDx will "Verify your insurance coverage", "Handle prior authorization if needed" and "Provide an estimate of potential out-of-pocket costs".Source

At order entry, ask for the specific findings each major payer requires, generate the medical necessity letter from the answers and AAP guidance, and flag gaps before submission. Show the clinician the authorization status in the portal and in Epic.

Faster approvals mean faster results for families and fewer abandoned orders, and they turn RCM work into a selling point for reps.

• Payer rules change

  Maintain prompts monthly.

• HiringProduct Lead, Revenue Cycle Management (posted October 20, 2026): first focus on "improving prior authorization, automating document intake, identifying coverage earlier, increasing clinical completeness"; KPIs include "coverage found rate, self-pay-to-billable conversion", "packets complete at first submission" and "patient financial experience and self-pay".Source
• Your websiteHow to order: a new clinician registers in the provider portal and "Our team will verify your new account"; anyone needing to order immediately is pointed to their assigned Regional Account Executive or Client Success Manager; Epic Aura users can order in the EHR; "Providing detailed and complete information upfront" can "Increase the likelihood that testing will be approved by insurance."Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source
• HiringEHR hiring: an Epic Analyst (posted October 12, 2026) whose objective is to "Enable smooth and swift Epic Aura integration projects with new customers quarterly", and an EHR Implementation Manager familiar with "Epic, Aura, Cerner, eClinicalWorks, and other Electronic Health Record platforms".Source

Estimate eligible children per practice from claims or practice size, compare with GeneDx orders, and give each RAE a ranked list of high-potential, low-ordering practices with the reason (coverage, documentation, awareness). Re-rank monthly.

Reps with 4.5 field days a week need the right doors; ranking by gap rather than by past orders finds new growth.

• Data privacy

  Use practice-level aggregates only.

• HiringPrincipal, Commercial and Growth Analytics (posted October 15, 2026): "You own the analytical answer to GeneDx's top-line questions: how volume grows, what drives it, and how it turns into revenue", as "principal analytics advisor to the Chief Commercial Officer's organization", working "with the leverage of AI agents in place of a team".Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source
• News coverageSecond quarter 2026 (reported August 3, 2026): revenue $114.4 million, up 11%; exome and genome test revenue $100.3 million, up 17%; exome and genome results 30,785, up 32%; full-year guidance of $475-490 million with exome and genome volume growth of at least 30%.Source
• Your blogSAVES-Kids (published October 2, 2026): in 5,821 Medicaid-covered children, stepwise testing "added an average of 19 months and $2,039 in genetic testing costs before" exome or genome sequencing; first-tier sequencing was associated with "$294 in savings per patient per year"; "some plans continue to require prior genetic testing before authorizing ES/GS".Source

List the plans that still require prior testing, prepare a two-page brief per plan using SAVES-Kids and society guidance, and request policy meetings with their medical directors, jointly with clinicians and advocacy groups where possible.

One policy change converts many practices at once, which no amount of rep visits can.

• Slow policy cycles

  Prioritize plans with upcoming policy reviews.

• Your blogSAVES-Kids (published October 2, 2026): in 5,821 Medicaid-covered children, stepwise testing "added an average of 19 months and $2,039 in genetic testing costs before" exome or genome sequencing; first-tier sequencing was associated with "$294 in savings per patient per year"; "some plans continue to require prior genetic testing before authorizing ES/GS".Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source
• Your websiteHomepage: "Preferred by more than 75,000 clinicians"; "Covered by most major insurers, with Medicaid coverage in 38 states"; "1M+ Exomes and genomes sequenced" in one block and "nearly 1 million exomes and genomes, and 7 million phenotypic data points" in the Infinity block; the carousel still promotes "Prenatal Webinar | July 8 at 3 pm ET"; visible typos such as "genoome sequencing" and "inheritedconditions".Source
• HiringProduct Lead, Revenue Cycle Management (posted October 20, 2026): first focus on "improving prior authorization, automating document intake, identifying coverage earlier, increasing clinical completeness"; KPIs include "coverage found rate, self-pay-to-billable conversion", "packets complete at first submission" and "patient financial experience and self-pay".Source

Survey ordering and prospective practices on their EHR, publish an "order from your EHR" page with the options that exist today (Epic Aura, portal, any lab interfaces) and a request form for others, and use the demand data to prioritize the next integration.

Ordering inside the tools practices already use removes a step, and the request form shows where to build.

• Integration timelines

  Offer portal shortcuts meanwhile.

• HiringEHR hiring: an Epic Analyst (posted October 12, 2026) whose objective is to "Enable smooth and swift Epic Aura integration projects with new customers quarterly", and an EHR Implementation Manager familiar with "Epic, Aura, Cerner, eClinicalWorks, and other Electronic Health Record platforms".Source
• Your websiteEpic Aura page: ordering and results inside Epic, a testimonial from a pediatric geneticist at a university health system, release notes, and a "Bring GeneDx into your EHR" form. No other EHR is named on the site.Source
• Your websiteHow to order: a new clinician registers in the provider portal and "Our team will verify your new account"; anyone needing to order immediately is pointed to their assigned Regional Account Executive or Client Success Manager; Epic Aura users can order in the EHR; "Providing detailed and complete information upfront" can "Increase the likelihood that testing will be approved by insurance."Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source

Publish a lookup where a pharma user enters a gene or condition and sees rounded cohort size, share with parental data, ancestry mix and claims linkage, with small cells suppressed. Gate deeper detail behind a request form. Add two anonymized partner case studies.

Researchers check feasibility first; showing it instantly qualifies leads and shows the dataset's depth for their specific program.

• Privacy concerns

  Aggregate only, suppress small groups.

• HiringDirector of Business Development, Biopharma Partnerships (posted October 13, 2026): grows "real-world data (RWD) and real-world evidence (RWE) partnerships" with pharma, biotech, digital health and medtech, owning "$2M-$10M+ MSAs", and will "Represent GeneDx at major industry conferences ... to elevate brand visibility and generate inbound opportunities".Source
• Your websiteBiopharma page: Infinity with "9M+ structured phenotypic data points" in one section and "7 million+ Phenotypic datapoints" further down; "400K contactable patients and providers"; "92% overlapping patient tokens with Komodo's Research Dataset"; "More than 50% of data is from non-European ancestry"; teams served are Clinical Development, Medical Affairs, RWE and HEOR; the call to action is "Contact our team" and there are no partner case studies.Source
• Your websiteProvider resources: six de-identified case studies (short stature, epilepsy, developmental delay, cerebral palsy, prenatal), webinars including "Beyond ICD codes: unlocking rare disease insights with genomics and claims-based data", a clinical guidelines page and a newborn screening page; GeneDx says its "150+ genetics experts" support clinicians and patients.Source

Translate the family path first: the quiz, "Talk to your doctor", billing and financial assistance, consent and sample collection. Add the Spanish parent handout to the pediatrician kit and use hreflang.

Families who understand the process finish it, and parents asking their doctor is a proven path to orders.

• Support in Spanish

  Confirm phone support coverage first.

• SitemapSitemap (206 URLs, read October 21, 2026): 61 blog posts, 41 provider pages, 23 patient pages, 17 conference pages, 7 webinars; specialty pages for general pediatrics, pediatric neurology, geneticists and genetic counselors, and maternal-fetal medicine; the only Spanish item is one rapid genome patient brochure, and no page has a Spanish version.Source
• Your websiteFamilies: an "Is genetic testing right for you?" quiz, a "Talk to your doctor" page, and a billing page saying GeneDx will "Verify your insurance coverage", "Handle prior authorization if needed" and "Provide an estimate of potential out-of-pocket costs".Source
• Your blogSAVES-Kids (published October 2, 2026): in 5,821 Medicaid-covered children, stepwise testing "added an average of 19 months and $2,039 in genetic testing costs before" exome or genome sequencing; first-tier sequencing was associated with "$294 in savings per patient per year"; "some plans continue to require prior genetic testing before authorizing ES/GS".Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source

Publish a developmental-behavioral pediatrics page: indications, AAP guidance, results that change management, ordering, coverage lookup and case studies. Use it after SDBP and in specialty rep outreach.

A specialty page speaks to a high-volume referral audience in its own terms.

• Overlap with other pages

  Link rather than duplicate.

• Your websiteConferences & Events page: Society for Developmental and Behavioral Pediatrics (October 23-27), Becker's Healthcare CEO + CFO (November 2-5), NSGC (November 10-14) and American Epilepsy Society (December 4-8, booth #1805). Every event card carries the same "Journal of Genetic Counseling" label.Source
• SitemapSitemap (206 URLs, read October 21, 2026): 61 blog posts, 41 provider pages, 23 patient pages, 17 conference pages, 7 webinars; specialty pages for general pediatrics, pediatric neurology, geneticists and genetic counselors, and maternal-fetal medicine; the only Spanish item is one rapid genome patient brochure, and no page has a Spanish version.Source
• HiringRegional Account Executive - Specialty (DC/Alexandria, posted October 15, 2026): focused "within genetics & pediatric segments", "Accountable for lead generation in an assigned territory" and for "physician and staff satisfaction"; "Implements agreed upon sales and marketing plans".Source
• Your websiteProvider resources: six de-identified case studies (short stature, epilepsy, developmental delay, cerebral palsy, prenatal), webinars including "Beyond ICD codes: unlocking rare disease insights with genomics and claims-based data", a clinical guidelines page and a newborn screening page; GeneDx says its "150+ genetics experts" support clinicians and patients.Source

Run a four-part series: when to order, documentation and coverage, explaining results to parents, and positive and VUS results. Explore accreditation through an accredited provider, and record each session for reps to share.

Education is the reps' main tool, and recorded sessions scale it beyond in-person lunches.

• Promotional concerns

  Keep accredited content independent.

• Your websiteProvider resources: six de-identified case studies (short stature, epilepsy, developmental delay, cerebral palsy, prenatal), webinars including "Beyond ICD codes: unlocking rare disease insights with genomics and claims-based data", a clinical guidelines page and a newborn screening page; GeneDx says its "150+ genetics experts" support clinicians and patients.Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source

At the end of the quiz, offer a one-page summary for the child's doctor: the concerns noted, the relevant AAP guidance, how to order and the coverage lookup. Ask permission to email reminders before the appointment.

Parent requests open doors for reps, and a clinician-ready note makes the request credible.

• Collecting health data

  Keep answers on the device unless the parent opts in.

• Your websiteFamilies: an "Is genetic testing right for you?" quiz, a "Talk to your doctor" page, and a billing page saying GeneDx will "Verify your insurance coverage", "Handle prior authorization if needed" and "Provide an estimate of potential out-of-pocket costs".Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source

After a non-diagnostic exome or genome, send the clinician a clear next-steps note (when to consider genome after exome, what new information would help, any reanalysis GeneDx offers) and check in at a set interval.

Clear follow-up keeps the case with GeneDx and shows clinicians the dataset's value over time.

• Seen as upselling

  Base every note on clinical guidance.

• Your websiteProvider resources: six de-identified case studies (short stature, epilepsy, developmental delay, cerebral palsy, prenatal), webinars including "Beyond ICD codes: unlocking rare disease insights with genomics and claims-based data", a clinical guidelines page and a newborn screening page; GeneDx says its "150+ genetics experts" support clinicians and patients.Source
• Your websiteHomepage: "Preferred by more than 75,000 clinicians"; "Covered by most major insurers, with Medicaid coverage in 38 states"; "1M+ Exomes and genomes sequenced" in one block and "nearly 1 million exomes and genomes, and 7 million phenotypic data points" in the Infinity block; the carousel still promotes "Prenatal Webinar | July 8 at 3 pm ET"; visible typos such as "genoome sequencing" and "inheritedconditions".Source
• Your websiteBiopharma page: Infinity with "9M+ structured phenotypic data points" in one section and "7 million+ Phenotypic datapoints" further down; "400K contactable patients and providers"; "92% overlapping patient tokens with Komodo's Research Dataset"; "More than 50% of data is from non-European ancestry"; teams served are Clinical Development, Medical Affairs, RWE and HEOR; the call to action is "Contact our team" and there are no partner case studies.Source

Package a pathway: Epic Aura order sets for GDD/ID and epilepsy, prior authorization support, genetic counseling, and a quarterly dashboard of time to diagnosis and avoided stepwise tests. Sign three health systems and publish results.

A measured pathway moves the decision from individual clinicians to the system and locks in volume.

• Long implementations

  Start with systems already integrated.

• HiringEHR hiring: an Epic Analyst (posted October 12, 2026) whose objective is to "Enable smooth and swift Epic Aura integration projects with new customers quarterly", and an EHR Implementation Manager familiar with "Epic, Aura, Cerner, eClinicalWorks, and other Electronic Health Record platforms".Source
• Your websiteEpic Aura page: ordering and results inside Epic, a testimonial from a pediatric geneticist at a university health system, release notes, and a "Bring GeneDx into your EHR" form. No other EHR is named on the site.Source
• Your websiteConferences & Events page: Society for Developmental and Behavioral Pediatrics (October 23-27), Becker's Healthcare CEO + CFO (November 2-5), NSGC (November 10-14) and American Epilepsy Society (December 4-8, booth #1805). Every event card carries the same "Journal of Genetic Counseling" label.Source
• Your blogSAVES-Kids (published October 2, 2026): in 5,821 Medicaid-covered children, stepwise testing "added an average of 19 months and $2,039 in genetic testing costs before" exome or genome sequencing; first-tier sequencing was associated with "$294 in savings per patient per year"; "some plans continue to require prior genetic testing before authorizing ES/GS".Source
• HiringProduct Lead, Revenue Cycle Management (posted October 20, 2026): first focus on "improving prior authorization, automating document intake, identifying coverage earlier, increasing clinical completeness"; KPIs include "coverage found rate, self-pay-to-billable conversion", "packets complete at first submission" and "patient financial experience and self-pay".Source

Offer sponsors a consented recontact service: identify eligible genetically confirmed patients, contact their clinicians under an approved protocol, and report enrollment. Price per program and pair it with data agreements.

Recruitment is the costliest bottleneck in rare disease development, and solving it makes GeneDx a long-term partner rather than a data vendor.

• Patient trust

  Clinician-mediated contact only, with clear opt-out.

• Your websiteBiopharma page: Infinity with "9M+ structured phenotypic data points" in one section and "7 million+ Phenotypic datapoints" further down; "400K contactable patients and providers"; "92% overlapping patient tokens with Komodo's Research Dataset"; "More than 50% of data is from non-European ancestry"; teams served are Clinical Development, Medical Affairs, RWE and HEOR; the call to action is "Contact our team" and there are no partner case studies.Source
• HiringDirector of Business Development, Biopharma Partnerships (posted October 13, 2026): grows "real-world data (RWD) and real-world evidence (RWE) partnerships" with pharma, biotech, digital health and medtech, owning "$2M-$10M+ MSAs", and will "Represent GeneDx at major industry conferences ... to elevate brand visibility and generate inbound opportunities".Source
• Competitor researchRivals' own homepages: Invitae (Labcorp), "Genetic testing services"; Baylor Genetics, "Answers Beyond the Genome"; Variantyx, "We See More In Every Genetic Test", whole-genome diagnostics for rare disorders; PreventionGenetics, whole genome and exome sequencing "with a team of genetic experts for step-by-step support"; Ambry Genetics.See the research Source

Pick five countries with the most volume, publish country pages with ordering, shipping, payment and local partner information, and build a partner kit for distributors and national programs using Enterprise.

Clear country paths reduce friction for clinicians abroad and give distributors a reason to lead with GeneDx.

• Local regulation

  Review each country before publishing.

• Your websiteInternational page: "40+ countries", "75K+ healthcare providers globally", GeneDx Enterprise software for labs to run analysis in their own lab, "320+ genetics and bioinformatics experts"; the only country ordering checklist is for Canada.Source
• SitemapSitemap (206 URLs, read October 21, 2026): 61 blog posts, 41 provider pages, 23 patient pages, 17 conference pages, 7 webinars; specialty pages for general pediatrics, pediatric neurology, geneticists and genetic counselors, and maternal-fetal medicine; the only Spanish item is one rapid genome patient brochure, and no page has a Spanish version.Source
• Competitor researchRivals' own homepages: Invitae (Labcorp), "Genetic testing services"; Baylor Genetics, "Answers Beyond the Genome"; Variantyx, "We See More In Every Genetic Test", whole-genome diagnostics for rare disorders; PreventionGenetics, whole genome and exome sequencing "with a team of genetic experts for step-by-step support"; Ambry Genetics.See the research Source

Write short, reviewed answers to the 30 most common parent and clinician questions with FAQ structured data, cite the AAP guidance and GeneDx data, and track monthly which sources assistants cite.

Assistants quote clear answers from authoritative pages; GeneDx's data makes it a natural source.

• Medical advice concerns

  Frame as information and point to clinicians.

• Competitor researchRivals' own homepages: Invitae (Labcorp), "Genetic testing services"; Baylor Genetics, "Answers Beyond the Genome"; Variantyx, "We See More In Every Genetic Test", whole-genome diagnostics for rare disorders; PreventionGenetics, whole genome and exome sequencing "with a team of genetic experts for step-by-step support"; Ambry Genetics.See the research Source
• Your websiteFamilies: an "Is genetic testing right for you?" quiz, a "Talk to your doctor" page, and a billing page saying GeneDx will "Verify your insurance coverage", "Handle prior authorization if needed" and "Provide an estimate of potential out-of-pocket costs".Source
• Your blogSAVES-Kids (published October 2, 2026): in 5,821 Medicaid-covered children, stepwise testing "added an average of 19 months and $2,039 in genetic testing costs before" exome or genome sequencing; first-tier sequencing was associated with "$294 in savings per patient per year"; "some plans continue to require prior genetic testing before authorizing ES/GS".Source
• SitemapSitemap (206 URLs, read October 21, 2026): 61 blog posts, 41 provider pages, 23 patient pages, 17 conference pages, 7 webinars; specialty pages for general pediatrics, pediatric neurology, geneticists and genetic counselors, and maternal-fetal medicine; the only Spanish item is one rapid genome patient brochure, and no page has a Spanish version.Source

Package counseling as a practice benefit: guaranteed pre-test and results counseling appointments for families of ordering practices, booked from the portal, with a target time to appointment. Reps lead with it.

Removing the hardest part of the process for a generalist is a stronger reason to order than any test feature.

• Capacity limits

  Grow by region alongside rep hiring.

• Your websiteProvider resources: six de-identified case studies (short stature, epilepsy, developmental delay, cerebral palsy, prenatal), webinars including "Beyond ICD codes: unlocking rare disease insights with genomics and claims-based data", a clinical guidelines page and a newborn screening page; GeneDx says its "150+ genetics experts" support clinicians and patients.Source
• HiringGeneDx lists 17 openings, 11 of them remote, including RCM and financial systems roles, a Clinical Genomics Scientist at Fabric Genomics, and a recruiting post to meet genetic counselors at the NSGC Annual Conference in November 2026.Source
• HiringRegional Account Executive - General Pediatrics (Colorado, posted September 21, 2026): "Your primary call points will be General Pediatricians"; the role will "drive adoption of genetic testing in general pediatric practices", "Lead educational efforts within the territory" (in-office appointments, physician lunches and dinners) with "4.5 days per week" in the field.Source
• Your websiteGeneral Pediatrics page: "The AAP now recommends exome (+CMA) as first-line tests for GDD and ID"; "82% of patients are covered"; "Medicaid coverage in 37 states with our Financial Assistance Program"; results "typically within 2-4 weeks"; calls to action "Order a Test" and "Contact a Rep". There is no way to see which states or plans cover first-line exome.Source